{"organizations": [], "uuid": "02c0bd70fb7a205f0e78fc92181306095de72177", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180205.html", "section_title": "Archive News &amp; Video for Monday, 05 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cti-biopharma-announces-launch-of/brief-cti-biopharma-announces-launch-of-follow-on-offering-idUSASB0C3WS", "country": "US", "domain_rank": 408, "title": "BRIEF-CTI Biopharma Announces Launch Of Follow-On Offering", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.782, "site_type": "news", "published": "2018-02-05T21:38:00.000+02:00", "replies_count": 0, "uuid": "02c0bd70fb7a205f0e78fc92181306095de72177"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cti-biopharma-announces-launch-of/brief-cti-biopharma-announces-launch-of-follow-on-offering-idUSASB0C3WS", "ord_in_thread": 0, "title": "BRIEF-CTI Biopharma Announces Launch Of Follow-On Offering", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "cti biopharma corp", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 5 (Reuters) -\n* CTI BIOPHARMA ANNOUNCES LAUNCH OF FOLLOW-ON OFFERING * CTI BIOPHARMA CORP - INTENDS TO USE NET PROCEEDS OF OFFERING TO COMPLETE PAC203 CLINICAL TRIAL, COMPLETE REVIEW OF PACRITINIB MAA BY EMA, AMONG OTHERS Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-05T21:38:00.000+02:00", "crawled": "2018-02-07T00:20:13.002+02:00", "highlightTitle": ""}